Merck
MRK
$79.06
Share price
-0.29%
Change (1 day)
-39.52%
Change (1 year)
Categories
Merck (MRK) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : $66.72 Billion USD
According to Merck's latest financial reports the company's total liabilities are $66.72 Billion USD. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Merck - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | $70.73 B | 2.45% |
| 2023-12-31 | $69.04 B | 9.41% |
| 2022-12-31 | $63.10 B | -6.43% |
| 2021-12-31 | $67.43 B | 1.89% |
| 2020-12-31 | $66.18 B | 13.34% |
| 2019-12-31 | $58.39 B | 4.74% |
| 2018-12-31 | $55.75 B | 4.6% |
| 2017-12-31 | $53.30 B | -3.21% |
| 2016-12-31 | $55.06 B | -3.23% |
| 2015-12-31 | $56.91 B | 15.26% |
| 2014-12-31 | $49.37 B | -7.4% |
| 2013-12-31 | $53.31 B | 5.23% |
| 2012-12-31 | $50.66 B | 5.16% |
| 2011-12-31 | $48.18 B | -1.62% |
| 2010-12-31 | $48.97 B | -3.65% |
| 2009-12-31 | $50.82 B | 95.28% |
| 2008-12-31 | $26.02 B | -6.23% |
| 2007-12-31 | $27.75 B | 12.82% |
| 2006-12-31 | $24.60 B | 0.59% |
| 2005-12-31 | $24.46 B | 6.92% |
| 2004-12-31 | $22.87 B | 8.45% |
| 2003-12-31 | $21.09 B | -13.66% |
| 2002-12-31 | $24.43 B | 5.61% |
| 2001-12-31 | $23.13 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $117.39 B | 75.94% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $115.56 B | 73.20% | 🇺🇸 USA |
 Eli Lilly LLY | $73.54 B | 10.22% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $74.97 B | 12.38% | 🇺🇸 USA |
 Sanofi SNY | $62.20 B | -6.76% | 🇫🇷 France |
 GlaxoSmithKline GSK | $60.87 B | -8.76% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $32.14 B | -51.82% | 🇮🇱 Israel |
 Novartis NVS | $61.48 B | -7.84% | 🇨🇭 Switzerland |
 Abbott Laboratories ABT | $32.38 B | -51.46% | 🇺🇸 USA |
 Amgen AMGN | $83.16 B | 24.64% | 🇺🇸 USA |